Nuclear kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells

American Journal of Pathology

Volumn 181, Issue 5, 2012, Pages 1836-1846

  Jones, Jacqueline ^a   Wang, Honghe ^a   Zhou, Jianjun ^a   Hardy, Shana ^a   Turner, Timothy ^a   Austin, David ^a   He, Qinghua ^a   Wells, Alan ^b   Grizzle, William E ^c   Yates, Clayton ^a  

^a TUSKEGEE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBRONECTIN; KAISO PROTEIN; NERVE CELL ADHESION MOLECULE; NUCLEAR PROTEIN; RNA; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UVOMORULIN;

AFRICAN AMERICAN; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL CONTACT; CELL LINE; CELL MIGRATION; CELL STRUCTURE; CYTOPLASM; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION;

CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TRANSCRIPTION FACTORS;

EID: 84868116560     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.08.008     Document Type: Article

References (50)

1. A. Stangelberger, M. Waldert, B. Djavan Prostate cancer in elderly men Rev Urol 10 2008 111 119
2. E.C. Lopes, E. Valls, M.E. Figueroa, A. Mazur, F.G. Meng, G. Chiosis, P.W. Laird, N. Schreiber-Agus, J.M. Greally, E. Prokhortchouk, A. Melnick Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines Cancer Res 68 2008 7258 7263
3. H.G. Yoon, D.W. Chan, A.B. Reynolds, J. Qin, J. Wong N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso Mol Cell 12 2003 723 734 (Pubitemid 37222492)
4. J.M. Daniel, A.B. Reynolds The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor Mol Cell Biol 19 1999 3614 3623 (Pubitemid 29193821)
5. A. Prokhortchouk, B. Hendrich, H. Jorgensen, A. Ruzov, M. Wilm, G. Georgiev, A. Bird, E. Prokhortchouk The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor Genes Dev 15 2001 1613 1618 (Pubitemid 32702582)
6. S.D. Dai, Y. Wang, Y. Miao, Y. Zhao, Y. Zhang, G.Y. Jiang, P.X. Zhang, Z.Q. Yang, E.H. Wang Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer BMC Cancer 9 2009 178
7. A. Wells, J.B. Welsh, C.S. Lazar, H.S. Wiley, G.N. Gill, M.G. Rosenfeld Ligand-induced transformation by a noninternalizing epidermal growth factor receptor Science 247 1990 962 964
8. U. Manne, R.B. Myers, S. Srivastava, W.E. Grizzle Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer J Natl Cancer Inst 89 1997 585 586
9. W. Grizzle, R. Myers, U. Manne, C. Stockard, L. Harkins, S. Srivastava Factors Affecting Immunohistochemical Evaluation of Biomarker Expression in Neoplasia M.Ha.Z. Walaszek, 1998 Humana Press, Inc New Jersey 161 179
10. T.R. Graham, H.E. Zhau, V.A. Odero-Marah, A.O. Osunkoya, K.S. Kimbro, M. Tighiouart, T. Liu, J.W. Simons, R.M. O'Regan Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells Cancer Res 68 2008 2479 2488 (Pubitemid 351521824)
11. C.C. Yates, D. Whaley, P. Kulasekeran, W.W. Hancock, B. Lu, R. Bodnar, J. Newsome, P.A. Hebda, A. Wells Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor Am J Pathol 171 2007 484 495 (Pubitemid 47344681)
12. J.M. Daniel, C.M. Spring, H.C. Crawford, A.B. Reynolds, A. Baig The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides Nucleic Acids Res 30 2002 2911 2919 (Pubitemid 34778152)
13. H. Xie, T. Turner, M.H. Wang, R.K. Singh, G.P. Siegal, A. Wells In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals Clin Exp Metastasis 13 1995 407 419
14. T. Turner, P. Chen, L.J. Goodly, A. Wells EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells Clin Exp Metastasis 14 1996 409 418 (Pubitemid 26363215)
15. Y. Gan, C. Shi, L. Inge, M. Hibner, J. Balducci, Y. Huang Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells Oncogene 29 2010 4947 4958
16. A.M. Traish, A. Morgentaler Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth Br J Cancer 101 2009 1949 1956
17. L.C. Li, H. Zhao, K. Nakajima, B.R. Oh, L.A. Ribeiro Filho, P. Carroll, R. Dahiya Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer J Urol 166 2001 705 709 (Pubitemid 32652304)
18. C.C. Yates, C.R. Shepard, D.B. Stolz, A. Wells Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin Br J Cancer 96 2007 1246 1252 (Pubitemid 46625074)
19. J. Chunthapong, E.A. Seftor, Z. Khalkhali-Ellis, R.E. Seftor, S. Amir, D.M. Lubaroff, P.M. Heidger Jr, M.J. Hendrix Dual roles of E-cadherin in prostate cancer invasion J Cell Biochem 91 2004 649 661
20. A.B. Reynolds, R.H. Carnahan Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer Semin Cell Dev Biol 15 2004 657 663 (Pubitemid 39550245)
21. Y. Miao, N. Liu, Y. Zhang, Y. Liu, J.H. Yu, S.D. Dai, H.T. Xu, E.H. Wang p120ctn isoform 1 expression significantly correlates with abnormal expression of E-cadherin and poor survival of lung cancer patients Med Oncol 27 2010 880 886
22. A. Soubry, J. van Hengel, E. Parthoens, C. Colpaert, E. Van Marck, D. Waltregny, A.B. Reynolds, F. van Roy Expression and nuclear location of the transcriptional repressor Kaiso is regulated by the tumor microenvironment Cancer Res 65 2005 2224 2233 (Pubitemid 40490131)
23. A. Prokhortchouk, O. Sansom, J. Selfridge, I.M. Caballero, S. Salozhin, D. Aithozhina, L. Cerchietti, F.G. Meng, L.H. Augenlicht, J.M. Mariadason, B. Hendrich, A. Melnick, E. Prokhortchouk, A. Clarke, A. Bird Kaiso-deficient mice show resistance to intestinal cancer Mol Cell Biol 26 2006 199 208
24. K.F. Kelly, C.M. Spring, A.A. Otchere, J.M. Daniel NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression J Cell Sci 117 2004 2675 2686 (Pubitemid 38997251)
25. J.I. Park, S.W. Kim, J.P. Lyons, H. JI, T.T. Nguyen, K. Cho, M.C. Barton, T. Deroo, K. Vleminckx, R.T. Moon, P.D. McCrea Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets Dev Cell 8 2005 843 854 (Pubitemid 40754056)
26. C. Amalinei [Reciprocal epithelio-stromal interactions in normal and neoplastic prostate] Romanian Rev Med Chir Soc Med Nat Iasi 110 2006 391 398
27. J. Lin, M.R. Freeman Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells Prostate 54 2003 1 7 (Pubitemid 36043830)
28. G. Fechner, G. Muller, D. Schmidt, S. Garbe, S. Hauser, P. Vaupel, S.C. Muller Evaluation of hypoxia-mediated growth factors in a novel bladder cancer animal model Anticancer Res 27 2007 4225 4231
29. A. Angelucci, G.L. Gravina, N. Rucci, D. Millimaggi, C. Festuccia, P. Muzi, A. Teti, C. Vicentini, M. Bologna Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice Endocr Relat Cancer 13 2006 197 210
30. C. Yates, A. Wells, T. Turner Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline Br J Cancer 92 2005 366 375 (Pubitemid 40343154)
31. J.M. Daniel, R.C. Ireton, A.B. Reynolds Monoclonal antibodies to Kaiso: a novel transcription factor and p120ctn-binding protein Hybridoma 20 2001 159 166 (Pubitemid 32881310)
32. A. Mamoune, J. Kassis, S. Kharait, S. Kloeker, E. Manos, D.A. Jones, A. Wells DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling Exp Cell Res 299 2004 91 100 (Pubitemid 39078384)
33. A. Wells, C. Yates, C.R. Shepard E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas Clin Exp Metastasis 25 2008 621 628
34. C. Yates, C.R. Shepard, G. Papworth, A. Dash, D. Beer Stolz, S. Tannenbaum, L. Griffith, A. Wells Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression Adv Cancer Res 97 2007 225 246 (Pubitemid 46528990)
35. A.U. Jawhari, M.J. Farthing, M. Pignatelli The E-cadherin/epidermal growth factor receptor interaction: a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation J Pathol 187 1999 155 157 (Pubitemid 29037043)
36. J.R. Graff, J.G. Herman, R.G. Lapidus, H. Chopra, R. Xu, D.F. Jarrard, W.B. Isaacs, P.M. Pitha, N.E. Davidson, S.B. Baylin E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas Cancer Res 55 1995 5195 5199
37. S.R. Ogden, L.E. Wroblewski, C. Weydig, J. Romero-Gallo, D.P. O'Brien, D.A. Israel, U.S. Krishna, B. Fingleton, A.B. Reynolds, S. Wessler, R.M. Peek Jr p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7 Mol Biol Cell 19 2008 4110 4121
38. K. Mimori, K. Yamashita, M. Ohta, K. Yoshinaga, K. Ishikawa, H. Ishii, T. Utsunomiya, G.F. Barnard, H. Inoue, M. Mori Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells Clin Cancer Res 10 2004 8243 8249 (Pubitemid 40053384)
39. J. Klingelhofer, H.D. Moller, E.U. Sumer, C.H. Berg, M. Poulsen, D. Kiryushko, V. Soroka, N. Ambartsumian, M. Grigorian, E.M. Lukanidin Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein FEBS J 276 2009 5936 5948
40. W.C. Reinhold, M.A. Reimers, A.K. Maunakea, S. Kim, S. Lababidi, U. Scherf, U.T. Shankavaram, M.S. Ziegler, C. Stewart, H. Kouros-Mehr, H. Cui, D. Dolginow, D.A. Scudiero, Y.G. Pommier, D.J. Munroe, A.P. Feinberg, J.N. Weinstein Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells Mol Cancer Ther 6 2007 391 403 (Pubitemid 46332442)
41. K. Gravdal, O.J. Halvorsen, S.A. Haukaas, L.A. Akslen A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer Clin Cancer Res 13 2007 7003 7011 (Pubitemid 350276881)
42. D. Zou, H.S. Yoon, D. Perez, R.J. Weeks, P. Guilford, B. Humar Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia J Pathol 218 2009 265 272
43. K.F. Kelly, A.A. Otchere, M. Graham, J.M. Daniel Nuclear import of the BTB/POZ transcriptional regulator Kaiso J Cell Sci 117 2004 6143 6152 (Pubitemid 40123978)
44. Q. Lu, L.J. Dobbs, C.W. Gregory, G.W. Lanford, M.P. Revelo, S. Shappell, Y.H. Chen Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer Hum Pathol 36 2005 1037 1048 (Pubitemid 41443254)
45. B.V. Kallakury, C.E. Sheehan, E. Winn-Deen, J. Oliver, H.A. Fisher, R.P. Kaufman Jr, J.S. Ross Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas Cancer 92 2001 2786 2795 (Pubitemid 33091915)
46. B. Shuch, M. Mikhail, J. Satagopan, P. Lee, H. Yee, C. Chang, C. Cordon-Cardo, S.S. Taneja, I. Osman Racial disparity of epidermal growth factor receptor expression in prostate cancer J Clin Oncol 22 2004 4725 4729
47. O.A. Timofeeva, X. Zhang, H.W. Ressom, R.S. Varghese, B.V. Kallakury, K. Wang, Y. Ji, A. Cheema, M. Jung, M.L. Brown, J.S. Rhim, A. Dritschilo Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men Int J Oncol 35 2009 751 760
48. S. Evans, C. Metcalfe, F. Ibrahim, R. Persad, Y. Ben-Shlomo Investigating black-white differences in prostate cancer prognosis: a systematic review and meta-analysis Int J Cancer 123 2008 430 435 (Pubitemid 351842030)
49. A.D. Berger, J. Satagopan, P. Lee, S.S. Taneja, I. Osman Differences in clinicopathologic features of prostate cancer between black and white patients treated in the 1990s and 2000s Urology 67 2006 120 124 (Pubitemid 43069269)
50. J.T. Nauseef, M.D. Henry Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle? Nat Rev Urol 8 2011 428 439